Publications by authors named "Kerrie Smith"

Claim this Profile
P
Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A.
Boris A Anokhin, William L Dean, Kerrie A Smith, Matthew J Flick, Robert A S Ariëns

FEBS J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications.
Katherine J Kearney, Nikoletta Pechlivani, Rhodri King, Christian Tiede, Fladia Phoenix, Kerrie A Smith

Blood· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cre/lox Studies Identify Resident Macrophages as the Major Source of Circulating Coagulation Factor XIII-A.
Cora M L Beckers, Kingsley R Simpson, Kathryn J Griffin, Jane M Brown, Lih T Cheah, Kerrie A Smith

Arterioscler Thromb Vasc Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
Katherine Kearney, Darren Tomlinson, Kerrie Smith, Ramzi Ajjan

Cardiovasc Diabetol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.
Kelly Njine Mouapi, Jacob D Bell, Kerrie A Smith, Robert A S Ariëns, Helen Philippou

Blood· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(±) cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors.
Craig A Avery, Richard J Pease, Kerrie Smith, May Boothby, Helen M Buckley

Eur J Med Chem· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal Bone Deposition Occurs in Mice Deficient in Factor XIII-A and Transglutaminase 2.
Paul A Cordell, Laura M Newell, Kristina F Standeven, Penelope J Adamson, Kingsley R Simpson, Kerrie A Smith

Matrix Biol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adipose tissue inflammation: feeding the development of type 2 diabetes mellitus.
Victoria R Richardson, Kerrie A Smith, Angela M Carter

Immunobiology· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity.
Ramzi A Ajjan, Toby Gamlen, Kristina F Standeven, Salihah Mughal, Katharina Hess, Kerrie A Smith

Blood· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The activation peptide cleft exposed by thrombin cleavage of FXIII-A(2) contains a recognition site for the fibrinogen α chain.
Kerrie A Smith, Richard J Pease, Craig A Avery, Jane M Brown, Penelope J Adamson

Blood· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.
Joanna-Marie Howes, Victoria R Richardson, Kerrie A Smith, Verena Schroeder, Riyaz Somani

Diab Vasc Dis Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions between factor XIII and the alphaC region of fibrinogen.
Kerrie A Smith, Penelope J Adamson, Richard J Pease, Jane M Brown, Anthony J Balmforth

Blood· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis